James D. Luketich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James D. Luketich has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Neil A. Christie
4 shared publications- Chandra Prakash Belani
Penn State Cancer Institute Penn State College of Medicine Hershey Pennsylvania USA
3 shared publications - Hiran Chrishantha Fernando
Department of Cardiothoracic Surgery, Boston University School of Medicine, Boston, MA USA
3 shared publications - Matthew J. Schuchert
Division of Thoracic and Foregut Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa
3 shared publications Neil A Christie
3 shared publicationsPercival O Buenaventura
3 shared publications
Latest Publications
- 31 May 2008
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 85 (5) , 1729-1734
Minimally-Invasive Esophagomyotomy in 200 Consecutive Patients: Factors Influencing Postoperative Outcomes
- 31 May 2008
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 85 (5) , 1729-1734
Minimally-Invasive Esophagomyotomy in 200 Consecutive Patients: Factors Influencing Postoperative Outcomes
- 29 February 2008
- Published by Elsevier in Thoracic Surgery Clinics
- Vol. 18 (1) , 93-105
Parenchymal-Sparing Resections: Why, When, and How
- 29 February 2008
- Published by Elsevier in Thoracic Surgery Clinics
- Vol. 18 (1) , 93-105
Parenchymal-Sparing Resections: Why, When, and How
- 29 February 2008
- Published by Elsevier in Journal of Surgical Research
- Vol. 144 (2) , 273
QS8. In Vitro Response of Non-Small Cell Lung Cancer to Signal Pathway Inhibitors Both Alone and in Combination With Cisplatin Vary According to Histologic Subtype
- 29 February 2008
- Published by Elsevier in Journal of Surgical Research
- Vol. 144 (2) , 273
QS8. In Vitro Response of Non-Small Cell Lung Cancer to Signal Pathway Inhibitors Both Alone and in Combination With Cisplatin Vary According to Histologic Subtype
- Open Access
- 21 February 2004
- Vol. 8 (1) , 19-23
Laparoscopic Roux-en-Y Gastric Bypass for Recalcitrant Gastroesophageal Reflux Disease in Morbidly Obese Patients
Gastroesophageal reflux disease (GERD) is commonly associated with morbid obesity (MO). Antireflux surgery has a higher failure rate in MO and addresses only one of the comorbidities present. This paper reviews the results of laparoscopic Rouxen-Y gastric bypass (LRYGBP) performed for recalcitrant GERD in MO. Patients with recalcitrant GERD and a body mass index (BMI)>35 undergoing LRYGBP were included. LRYGB included crural repair, creation of a small gastric pouch (30 mL), and intestinal bypass (150 to 180 cm). All patients were followed in clinic and by telephone. From February 1999 to April 2001, 57 patients (51 F, 6 M) with a mean age of 43 (range, 22 to 67) and a median BMI of 43 underwent LRYGBP. Hiatal hernia or esophagitis, or both, were present in 48, Barrett's in 2. LRYGBP was possible in 52 patients; 5 required open conversion. The median hospital stay was 3 days. Complications included 1 leak, 1 pulmonary emboli, 2 reoperations for internal roux limb hernia, and 7 gastrojejunal strictures. At a mean follow-up of 18 months (range, 3 to 30), all patients report improvement or no symptoms of GERD and a mean weight loss of 40 kg (range, 16 to 70). Quality of life scores (SF-36) were above national norms for physical and mental components (median 55, norms=50). GERD-health related quality of life median score was <1 (scale, 0 to 45, 0=asymptomatic, 45=worse). LRYGBP was effective for recalcitrant GERD in MO. LRYGBP also led to weight loss and improvement in other comorbidites. Surgeons with minimally invasive expertise should consider LRYGBP for treatment of GERD in the morbidly obese.
- 21 February 2004
- Vol. 8 (1) , 19-23
Open AccessLaparoscopic Roux-en-Y Gastric Bypass for Recalcitrant Gastroesophageal Reflux Disease in Morbidly Obese Patients
Gastroesophageal reflux disease (GERD) is commonly associated with morbid obesity (MO). Antireflux surgery has a higher failure rate in MO and addresses only one of the comorbidities present. This paper reviews the results of laparoscopic Rouxen-Y gastric bypass (LRYGBP) performed for recalcitrant GERD in MO. Patients with recalcitrant GERD and a body mass index (BMI)>35 undergoing LRYGBP were included. LRYGB included crural repair, creation of a small gastric pouch (30 mL), and intestinal bypass (150 to 180 cm). All patients were followed in clinic and by telephone. From February 1999 to April 2001, 57 patients (51 F, 6 M) with a mean age of 43 (range, 22 to 67) and a median BMI of 43 underwent LRYGBP. Hiatal hernia or esophagitis, or both, were present in 48, Barrett's in 2. LRYGBP was possible in 52 patients; 5 required open conversion. The median hospital stay was 3 days. Complications included 1 leak, 1 pulmonary emboli, 2 reoperations for internal roux limb hernia, and 7 gastrojejunal strictures. At a mean follow-up of 18 months (range, 3 to 30), all patients report improvement or no symptoms of GERD and a mean weight loss of 40 kg (range, 16 to 70). Quality of life scores (SF-36) were above national norms for physical and mental components (median 55, norms=50). GERD-health related quality of life median score was <1 (scale, 0 to 45, 0=asymptomatic, 45=worse). LRYGBP was effective for recalcitrant GERD in MO. LRYGBP also led to weight loss and improvement in other comorbidites. Surgeons with minimally invasive expertise should consider LRYGBP for treatment of GERD in the morbidly obese.
- 30 April 2003
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A810
Short-term outcome of collis-nissen gastroplasty using a wedge gastroplasty technique
- 30 April 2003
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , A810
Short-term outcome of collis-nissen gastroplasty using a wedge gastroplasty technique
- 26 December 2002
- Vol. 6 (4) , 299-304
Minimally Invasive Esophagectomy in the Elderly
In recent years, older patients are being referred for esophagectomy, and the associated morbidity and mortality is not well defined. Advances in minimally invasive techniques now allow minimally invasive esophagectomy (MIE) to be performed that may minimize the morbidity of this procedure. The objective of this report was to summarize our experience with MIE in the elderly. From February 1997 through February 2001, 41 patients (14 women, 27 men) 75 years of age or older (mean age 78, range 75 to 89) underwent esophagectomy (28 for adenocarcinoma, 7 squamous, 6 Barrett's with high-grade dysplasia). Esophagectomy was performed in a minimally invasive fashion in 41 patients. No open conversions were necessary. The median ICU stay was 1 day (range 1 to 34). The median hospital stay was 7 days (range 5 to 50). Major morbidity occurred in 19% of the cases and included 1 persistent air leak, 1 case of pneumonia with acute respiratory failure, 1 tracheal tear, 1 chylothorax, and 1 myocardial infarction. Three anastomotic leaks and 1 small bowel perforation occurred. All were recognized early and treated surgically. No perioperative mortalities took place. In our center, MIE was performed in elderly patients with an acceptable morbidity, low mortality, and reduced length of hospital stay compared with that in previous reports.
- 26 December 2002
- Vol. 6 (4) , 299-304
Minimally Invasive Esophagectomy in the Elderly
In recent years, older patients are being referred for esophagectomy, and the associated morbidity and mortality is not well defined. Advances in minimally invasive techniques now allow minimally invasive esophagectomy (MIE) to be performed that may minimize the morbidity of this procedure. The objective of this report was to summarize our experience with MIE in the elderly. From February 1997 through February 2001, 41 patients (14 women, 27 men) 75 years of age or older (mean age 78, range 75 to 89) underwent esophagectomy (28 for adenocarcinoma, 7 squamous, 6 Barrett's with high-grade dysplasia). Esophagectomy was performed in a minimally invasive fashion in 41 patients. No open conversions were necessary. The median ICU stay was 1 day (range 1 to 34). The median hospital stay was 7 days (range 5 to 50). Major morbidity occurred in 19% of the cases and included 1 persistent air leak, 1 case of pneumonia with acute respiratory failure, 1 tracheal tear, 1 chylothorax, and 1 myocardial infarction. Three anastomotic leaks and 1 small bowel perforation occurred. All were recognized early and treated surgically. No perioperative mortalities took place. In our center, MIE was performed in elderly patients with an acceptable morbidity, low mortality, and reduced length of hospital stay compared with that in previous reports.
- 1 September 2002
- Published by Springer Nature in Surgical Endoscopy
- Vol. 16 (9) , 1264-1266
Results of a randomized trial of HERMES-assisted versus non-HERMES-assisted laparoscopic antireflux surgery
Speech recognition technology is a recent development in minimally invasive surgery. This study was designed to assess the impact of HERMES on operating room efficiency and user satisfaction. Patients undergoing laparoscopic antireflux operations by surgeons experienced in minimally invasive surgery were randomized to HERMES-assisted or standard laparoscopic operations. The variables of interest were circulating nurse’s time spent adjusting devices that are voice-controlled by HERMES, number of adjustments to devices requested, and surgeon and nurse satisfaction measured on a scale from 1 (dissatisfied) to 10 (satisfied). A total of 30 cases were studied. In the non-HERMES cases, nurses were interrupted to make device adjustments an average of 15.3 times per case versus 0.33 times per case in the with-HERMES cases (pp=0.03). Average satisfaction scores for HERMES operations as opposed to non-HERMES operations were 9.2 versus 5.3 for nurses (pp<0.01). Physician and nurse acceptance of HERMES was very high because of the smoother interruption-free environment.
- 1 September 2002
- Published by Springer Nature in Surgical Endoscopy
- Vol. 16 (9) , 1264-1266
Results of a randomized trial of HERMES-assisted versus non-HERMES-assisted laparoscopic antireflux surgery
Speech recognition technology is a recent development in minimally invasive surgery. This study was designed to assess the impact of HERMES on operating room efficiency and user satisfaction. Patients undergoing laparoscopic antireflux operations by surgeons experienced in minimally invasive surgery were randomized to HERMES-assisted or standard laparoscopic operations. The variables of interest were circulating nurse’s time spent adjusting devices that are voice-controlled by HERMES, number of adjustments to devices requested, and surgeon and nurse satisfaction measured on a scale from 1 (dissatisfied) to 10 (satisfied). A total of 30 cases were studied. In the non-HERMES cases, nurses were interrupted to make device adjustments an average of 15.3 times per case versus 0.33 times per case in the with-HERMES cases (pp=0.03). Average satisfaction scores for HERMES operations as opposed to non-HERMES operations were 9.2 versus 5.3 for nurses (pp<0.01). Physician and nurse acceptance of HERMES was very high because of the smoother interruption-free environment.
- 1 August 2002
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 74 (2) , 328-332
Outcomes after minimally invasive reoperation for gastroesophageal reflux disease
- 1 August 2002
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 74 (2) , 328-332
Outcomes after minimally invasive reoperation for gastroesophageal reflux disease
- 1 December 2001
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 72 (6) , 1909-1913
Outcomes after minimally invasive esophagomyotomy
- 1 December 2001
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 72 (6) , 1909-1913
Outcomes after minimally invasive esophagomyotomy
- 31 October 2001
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 72 (4) , 1130-1135
Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett’s esophagus
- 31 October 2001
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 72 (4) , 1130-1135
Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett’s esophagus